Therapeutic Response of Ultrasound and Muscular Stretching in Temporomandibular Disorder Patients
NCT ID: NCT02139735
Last Updated: 2014-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2012-03-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Temporomandibular Disorders
NCT01187316
Thermograph Evaluation of Masticatory and Cervical Muscles After Physiotherapeutic Treatment in Tmd Subjects
NCT02822469
Effects of Mandibular Exercises Effect on Pain Perception and Sensitivity in Mandibular Myofascial Pain
NCT03339739
Effects of Focal Extracorporeal Shock Wave Therapy in the Treatment of Temporomandibular Disorders of Muscular Origin
NCT05907239
Effectiveness of Photobiomodulation and Manual Therapy Alone or Combined in TMD Patients
NCT03454581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ultrasound
3 MHz (Mega Hertz) ultrasound in continuous mode with an intensity of 1.0 W / cm ² was applied for 3 minutes in the TMJ (Temporomandibular joint) and masseter muscles bilaterally
Ultrasound associated with stretching
3 MHz ultrasound in continuous mode with an intensity of 1.0 W / cm ² was applied for 3 minutes in the TMJ and masseter muscles, bilaterally.
Active stretching of the masseter muscles with mouth opening and closed lips
Placebo
Turned off ultrasound application on area of TMJ and masseter muscle, bilaterally.
Ultrasound associated with stretchting
3 MHz ultrasound in continuous mode with an intensity of 1.0 W / cm ² was applied for 3 minutes in the TMJ and masseter muscles bilaterally.
Active stretching of the masseter muscles with mouth opening and closed lips
Ultrasound
3 MHz ultrasound in continuous mode with an intensity of 1.0 W / cm ² was applied for 3 minutes in the TMJ and masseter muscles bilaterally
Placebo
Turned off ultrasound application on area of TMJ and masseter muscle, bilaterally.
Placebo
Turned off ultrasound application on area of TMJ and masseter muscle, bilaterally.
Ultrasound
3 MHz ultrasound in continuous mode with an intensity of 1.0 W / cm ² was applied for 3 minutes in the TMJ and masseter muscles bilaterally
Ultrasound associated with stretching
3 MHz ultrasound in continuous mode with an intensity of 1.0 W / cm ² was applied for 3 minutes in the TMJ and masseter muscles, bilaterally.
Active stretching of the masseter muscles with mouth opening and closed lips
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound
3 MHz ultrasound in continuous mode with an intensity of 1.0 W / cm ² was applied for 3 minutes in the TMJ and masseter muscles bilaterally
Ultrasound associated with stretching
3 MHz ultrasound in continuous mode with an intensity of 1.0 W / cm ² was applied for 3 minutes in the TMJ and masseter muscles, bilaterally.
Active stretching of the masseter muscles with mouth opening and closed lips
Placebo
Turned off ultrasound application on area of TMJ and masseter muscle, bilaterally.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* women aged 20 to 35 years.
Exclusion Criteria
* history of orthopedic trauma involving the temporomandibular region , orofacial surgery or poor training ;
* analgesics , anti-inflammatories , muscle relaxants , antidepressants ;
* presence of acute TMJ pain ( last 3 months) ;
* have perform physical therapy or speech therapy for the past 6 months;
* periods of the end of the menstrual cycle (7 days prior to menstruation ) and onset of menstruation ( first 2 days ) were excluded for conducting evaluations of volunteers who did not use oral contraception and those who used it to break.
20 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal de Santa Maria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eliane Correa
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eliane C. Corrêa, Doctor
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal de Santa Maria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Federal de Santa Maria
Santa Maria, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UFSM-MO-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.